Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2011-07-15
Original SEC Filing: Click here

---

Webplus: CBPO/20110715/8-K/2_EX-99.1/000.htm SEC Original: exhibit99-1.htm
Company contact FOR RELEASE ON JULY 15, 2011 AT 8:30a.m. EDT (NY) China Biologic Evaluating Possible Effects from a Revised Provincial Plan on Plasma Collection Stations in Guizhou Province TAI’AN, China, July 15, 2011 /PRNewswire-Asia-FirstCall/ – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic,” or the “Company”), a leading plasma-based biopharmaceutical company in China, today announced that the Guizhou Provincial

---

---

Webplus: CBPO/20110715/8-K/1/000.htm SEC Original: d8k.htm
FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): July 15, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer ID No.) No. 14 East Hushan Road, Tai’an City, Shandong, 271000 People’s Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2011-07-15CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125